Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosis.

Ahmed Merza Mohammed T, Nouri Shawis T, Ahmad Merza Mohammad T, Al-Haideri M

Open source

DOI
10.1080/1750743x.2026.2676451
Published
2026 Apr-Apr
Container
Immunotherapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/1750743x.2026.2676451,
  title = {Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosis.},
  author = {Ahmed Merza Mohammed T and Nouri Shawis T and Ahmad Merza Mohammad T and Al-Haideri M},
  year = {2026},
  journal = {Immunotherapy},
  doi = {10.1080/1750743x.2026.2676451},
  url = {https://doi.org/10.1080/1750743x.2026.2676451}
}

RIS

TY  - JOUR
TI  - Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosis.
AU  - Ahmed Merza Mohammed T
AU  - Nouri Shawis T
AU  - Ahmad Merza Mohammad T
AU  - Al-Haideri M
PY  - 2026
JO  - Immunotherapy
DO  - 10.1080/1750743x.2026.2676451
UR  - https://doi.org/10.1080/1750743x.2026.2676451
ER  - 

APA

T, A. M. M., T, N. S., T, A. M. M., & M, A. (2026). Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosis.. Immunotherapy. https://doi.org/10.1080/1750743x.2026.2676451

Source records